Download Free Medical Asthma PowerPoint Presentation

Asthma PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : This medical presentation titled ""Asthma"" gives definition of asthma, lists triggers of asthma, talks about asthma pathophysiology, causes of airway obstruction and asthma clinical manifestations.

Tags : Allergy, Asthma, Reactive airway disease, Chronic inflammatory lung disease, Inflammation causes, obstruction in the airways, Allergens, Exercise, Respiratory Infections, Nose and Sinus problems, Drugs and Food Additives, GERD, Emotional Stress, Asthma Pathophysiology, Bronchospasm, Airway inflammation, Airway Obstruction, Oximetry, Allergy testing, Blood levels of eosinophils, Sputum culture and sensitivity, Collaborative Care, Bronchodilators, Antiinflammatory drugs, Anti-inflammatory drugs

Published on : Apr 24, 2021 | Views : 6202 | Downloads : 27

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Asthma
Slide 2-

Asthma Definition Reactive airway disease Chronic inflammatory lung disease Inflammation causes varying degrees of obstruction in the airways Asthma is reversible in early stages
Slide 3-

Triggers of Asthma Allergens Exercise Respiratory Infections Nose and Sinus problems Drugs and Food Additives GERD Emotional Stress
Slide 4-

Early and Late Phases of Responses of Asthma Fig. 28-1
Slide 5-

Asthma Pathophysiology Bronchospasm Airway inflammation
Slide 6-

Asthma Pathophysiology Early-Phase Response Peaks 30-60 minutes post exposure, subsides 30-90 minutes later Characterized primarily by bronchospasm Increased mucous secretion, edema formation, and increased amounts of tenacious sputum Patient experiences wheezing, cough, chest tightness, and dyspnea
Slide 7-

Asthma Pathophysiology Late-Phase Response Characterized primarily by inflammation Histamine and other mediators set up a self-sustaining cycle increasing airway reactivity causing hyperresponsiveness to allergens and other stimuli Increased airway resistance leads to air trapping in alveoli and hyperinflation of the lungs If airway inflammation is not treated or does not resolve, may lead to irreversible lung damage
Slide 8-

Factors Causing Airway Obstruction in Asthma Fig. 28-3
Slide 9-

Summary of Pathophysiologic Features Reduction in airway diameter Increase in airway resistance r/t Mucosal inflammation Constriction of smooth muscle Excess mucus production
Slide 10-

Asthma Clinical Manifestations Unpredictable and variable Recurrent episodes of wheezing, breathlessness, cough, and tight chest
Slide 11-

Asthma Clinical Manifestations Expiration may be prolonged from a inspiration-expiration ratio of 1:2 to 1:3 or 1:4 Between attacks may be asymptomatic with normal or near-normal lung function
Slide 12-

Asthma Clinical Manifestations Wheezing is an unreliable sign to gauge severity of attack Severe attacks can have no audible wheezing due to reduction in airflow “Silent chest” is ominous sign of impending respiratory failure
Slide 13-

Asthma Clinical Manifestations Difficulty with air movement can create a feeling of suffocation Patient may feel increasingly anxious Mobilizing secretions may become difficult
Slide 14-

Asthma Clinical Manifestations Examination of the patient during an acute attack usually reveals signs of hypoxemia Restlessness Increased anxiety Inappropriate behavior Increased pulse and blood pressure Pulsus paradoxus (drop in systolic BP during inspiratory cycle >10)
Slide 15-

Asthma Complications Status asthmaticus Severe, life-threatening attack refractory to usual treatment where patient poses risk for respiratory failure
Slide 16-

Asthma Diagnostic Studies Detailed history and physical exam Pulmonary function tests Peak flow monitoring Chest x-ray ABGs
Slide 17-

Asthma Diagnostic Studies Oximetry Allergy testing Blood levels of eosinophils Sputum culture and sensitivity
Slide 18-

Asthma Collaborative Care Education Start at time of diagnosis Integrated into every step of clinical care Self-management Tailored to needs of patient Emphasis on evaluating outcome in terms of patient’s perceptions of improvement
Slide 19-

Asthma Collaborative Care Acute Asthma Episode O2 therapy should be started and monitored with pulse oximetry or ABGs in severe cases Inhaled -adrenergic agonists by metered dose using a spacer or nebulizer Corticosteroids indicated if initial response is insufficient
Slide 20-

Asthma Collaborative Care Acute Asthma Episode Therapy should continue until patient is breathing comfortably wheezing has disappeared pulmonary function study results are near baseline values
Slide 21-

Asthma Collaborative Care Status asthmaticus Most therapeutic measures are the same as for acute Increased frequency & dose of bronchodilators Continuous -adrenergic agonist nebulizer therapy may be given
Slide 22-

Asthma Collaborative Care Status asthmaticus IV corticosteroids Continuous monitoring Supplemental O2 to achieve values of 90% IV fluids are given due to insensible loss of fluids Mechanical ventilation is required if there is no response to treatment
Slide 23-

Asthma Drug Therapy Long-term control medications Achieve and maintain control of persistent asthma Quick-relief medications Treat symptoms of exacerbations
Slide 24-

Asthma Drug Therapy Bronchodilators -adrenergic agonists (e.g., albuterol, salbutamol[Ventolin]) Acts in minutes, lasts 4 to 8 hours Short-term relief of bronchoconstriction Treatment of choice in acute exacerbations
Slide 25-

Asthma Drug Therapy Bronchodilators Useful in preventing bronchospasm precipitated by exercise and other stimuli Overuse may cause rebound bronchospasm Too frequent use indicates poor asthma control and may mask severity
Slide 26-

Asthma Drug Therapy Bronchodilators (longer acting) 8 – 12 or 24 hr; useful for nocturnal asthma Avoid contact with tongue to decrease side effects Can be used in combination therapy with inhaled corticosteroid
Slide 27-

Asthma Drug Therapy Antiinflammatory drugs Corticosteroids (e.g., beclomethasone, budesonide) Suppress inflammatory response Inhaled form is used in long-term control Systemic form to control exacerbations and manage persistent asthma
Slide 28-

Asthma Drug Therapy Antiinflammatory drugs Corticosteroids Do not block immediate response to allergens, irritants, or exercise Do block late-phase response to subsequent bronchial hyperresponsiveness Inhibit release of mediators from macrophages and eosinophils
Slide 29-

Asthma Drug Therapy Anti-inflammatory drugs Mast cell stabilizers (e.g., cromolyn, nedocromil) Inhibit release of histamine Inhibit late-phase response Long-term administration can prevent and reduce bronchial hyper-reactivity Effective in exercise-induced asthma when used 10 to 20 minutes before exercise
Slide 30-

Asthma Drug Therapy Leukotriene modifiers (e.g. Singulair) Leukotriene – potent bronchco-constrictors and may cause airway edema and inflammation Have broncho-dilator and anti-inflammatory effects
Slide 31-

Asthma Patient Teaching Related to Drug Therapy Correct administration of drugs is a major factor in determining success in asthma management Some persons may have difficulty using an MDI and therefore should use a spacer or nebulizer DPI (dry powder inhaler) requires less manual dexterity and coordination
Slide 32-

Asthma Patient Teaching Related to Drug Therapy Inhalers should be cleaned by removing dust cap and rinsing with warm water -adrenergic agonists should be taken first if taking in conjunction with corticosteroids
Slide 33-

Nursing Management Nursing Diagnoses Ineffective airway clearance Anxiety Ineffective therapeutic regimen management
Slide 34-

Nursing Management Planning Normal or near-normal pulmonary function Normal activity levels No recurrent exacerbations of asthma or decreased incidence of asthma attacks Adequate knowledge to participate in and carry out management
Slide 35-

Nursing Management Health Promotion Teach patient to identify and avoid known triggers Use dust covers Use of scarves or masks for cold air Avoid aspirin or NSAIDs Desensitization can decrease sensitivity to allergens
Slide 36-

Nursing Management Health Promotion Prompt diagnosis and treatment of upper respiratory infections and sinusitis may prevent exacerbation Fluid intake of 2 to 3L every day
Slide 37-

Nursing Management Health Promotion Adequate nutrition Adequate sleep Take -adrenergic agonist 10 to 20 minutes prior to exercising
Slide 38-

Nursing Management Nursing Implementation Acute Intervention Monitor respiratory and cardiovascular systems Lung sounds Respiratory rate Pulse BP
Slide 39-

Nursing Management Nursing Implementation ABGs Pulse oximetry FEV and PEFR Work of breathing Response to therapy
Slide 40-

Nursing Management Nursing Implementation Nursing Interventions Administer O2 Bronchodilators Chest physiotherapy Medications (as ordered) Ongoing patient monitoring
Slide 41-

Nursing Management Nursing Implementation An important goal of nursing is to decrease the patient’s sense of panic Stay with patient Encourage slow breathing using pursed lips for prolonged expiration Position comfortably
Slide 42-

Nursing Management Nursing Implementation The patient must learn about medications and develop self-management strategies Patient and health care professional must monitor responsiveness to medication Patient must understand importance of continuing medication when symptoms are not present
Slide 43-

Nursing Management Nursing Implementation Important patient teaching: Seek medical attention for bronchospasm or when severe side effects occur Maintain good nutrition Exercise within limits of tolerance
Slide 44-

Nursing Management Nursing Implementation Important patient teaching (cont.): Patient must learn to measure their peak flow at least daily Asthmatics frequently do not perceive changes in their breathing
Slide 45-

Nursing Management Nursing Implementation Counseling may be indicated to resolve problems Relaxation therapies may help relax respiratory muscles and decrease respiratory rate
Slide 46-

Nursing Management Nursing Implementation Peak Flow Results Green zone Usually 80-100% of personal best Remain on medications
Slide 47-

Nursing Management Nursing Implementation Peak Flow Results Yellow zone Usually 50-80% of personal best Indicates caution Something is triggering asthma
Slide 48-

Nursing Management Nursing Implementation Peak Flow Results Red zone 50% or less of personal best Indicates serious problem Definitive action must be taken with health care provider